Bioshares Etf Performance

BBP -  USA Etf  

USD 50.79  0.14  0.28%

The etf shows a Beta (market volatility) of 0.5542, which signifies possible diversification benefits within a given portfolio. Let's try to break down what Bioshares's beta means in this case. As returns on the market increase, Bioshares Biotech returns are expected to increase less than the market. However, during the bear market, the loss on holding Bioshares Biotech will be expected to be smaller as well. Although it is extremely important to respect Bioshares Biotech historical returns, it is better to be realistic regarding the information on equity current trending patterns. The philosophy towards foreseeing future performance of any etf is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By analyzing Bioshares Biotech technical indicators, you can presently evaluate if the expected return of 0.0211% will be sustainable into the future.

Bioshares Etf Performance 

 
Refresh
 Bioshares Performance
1 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Bioshares Biotech Products are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy fundamental drivers, Bioshares Biotech is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the insiders. ...more

Bioshares Price Channel

Fifty Two Week Low47.71
Fifty Two Week High61.40

Bioshares Biotech Relative Risk vs. Return Landscape

If you would invest  5,037  in Bioshares Biotech Products on July 26, 2021 and sell it today you would earn a total of  42.00  from holding Bioshares Biotech Products or generate 0.83% return on investment over 90 days. Bioshares Biotech Products is generating 0.0211% of daily returns assuming volatility of 1.2962% on return distribution over 90 days investment horizon. In other words, 11% of etfs are less volatile than Bioshares, and above 99% of all equities are expected to generate higher returns over the next 90 days.
 Daily Expected Return (%) 
      Risk (%) 
Considering the 90-day investment horizon Bioshares Biotech is expected to generate 1.21 times less return on investment than the market. In addition to that, the company is 1.83 times more volatile than its market benchmark. It trades about 0.02 of its total potential returns per unit of risk. The DOW is currently generating roughly 0.04 per unit of volatility.

Bioshares Biotech Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Bioshares Biotech's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as Bioshares Biotech Products, and traders can use it to determine the average amount a Bioshares Biotech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0162

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsBBP
Estimated Market Risk
 1.3
  actual daily
 
 11 %
of total potential
 
1111
Expected Return
 0.02
  actual daily
 
 0 %
of total potential
 
00
Risk-Adjusted Return
 0.02
  actual daily
 
 1 %
of total potential
 
11
Based on monthly moving average Bioshares Biotech is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bioshares Biotech by adding it to a well-diversified portfolio.

About Bioshares Biotech Performance

To evaluate Bioshares Biotech Etf as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Bioshares Biotech generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Bioshares Etf's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Bioshares Biotech stock market performance in a much more refined way. At Macroaxis, we take it even further. The Macroaxis performance score is an integer between 0 and 100 that represents Bioshares's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. Bioshares Biotech is traded on NYSEArca Exchange in the United States.

Things to note about Bioshares Biotech

Checking the ongoing alerts about Bioshares Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Bioshares Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Bioshares Biotech Alerts

Equity Alerts and Improvement Suggestions

Bioshares Biotech is unlikely to experience financial distress in the next 2 years
The fund holds 97.81% of its assets under management (AUM) in equities
Continue to Trending Equities. Note that the Bioshares Biotech information on this page should be used as a complementary analysis to other Bioshares Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for Bioshares Etf analysis

When running Bioshares Biotech price analysis, check to measure Bioshares Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioshares Biotech is operating at the current time. Most of Bioshares Biotech's value examination focuses on studying past and present price action to predict the probability of Bioshares Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bioshares Biotech's price. Additionally, you may evaluate how the addition of Bioshares Biotech to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
The market value of Bioshares Biotech is measured differently than its book value, which is the value of Bioshares that is recorded on the company's balance sheet. Investors also form their own opinion of Bioshares Biotech's value that differs from its market value or its book value, called intrinsic value, which is Bioshares Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioshares Biotech's market value can be influenced by many factors that don't directly affect Bioshares Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioshares Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Bioshares Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioshares Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.